Dienvidāfrikas Republika - angļu - South African Health Products Regulatory Authority (SAHPRA)

adcock ingram limited - syrup - see ingredients - each 5,0 ml syrup contains guaifenesin 100,0 mg

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

h. lundbeck a.s. - sertindole 16 mg - film-coated tablet - 16 mg - sertindole 16 mg - sertindole

Beļģija - angļu - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

h. lundbeck a.s. - sertindole 4 mg - film-coated tablet - 4 mg - sertindole 4 mg - sertindole

Austrālija - angļu - APVMA (Australian Pesticides and Veterinary Medicines Authority)

darby's garden products - indole acetic acid as the sodium salt | naphthylacetic acid as the potassium salt - plant regulator - bowling and golf green turf | flower seedling | lawn | ornamental cut flower | repot, plant or transplant ornamentals | vegetabl - minimise transplant shock | prolong cut flower life | stimulating plant growth | stimulation of lateral growth

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sertindole 12mg - film coated tablet - 12 mg - active: sertindole 12mg excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry beige 03b27149 - sertindole is indicated for the treatment of schizophrenia. due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sertindole 16mg - film coated tablet - 16 mg - active: sertindole 16mg excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry pink 03b24027 (rose) - sertindole is indicated for the treatment of schizophrenia. due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sertindole 20mg - film coated tablet - 20 mg - active: sertindole 20mg excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry pink 03b24282 - sertindole is indicated for the treatment of schizophrenia. due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

pharmacy retailing (nz) ltd t/a healthcare logistics - sertindole 4mg - film coated tablet - 4 mg - active: sertindole 4mg excipient: croscarmellose sodium hyprolose lactose monohydrate magnesium stearate maize starch microcrystalline cellulose opadry yellow 03b22082 - sertindole is indicated for the treatment of schizophrenia. due to cardiovascular safety concerns, sertindole should only be used for patients intolerant to at least one other antipsychotic agent. sertindole should not be used in emergency situations for urgent relief of symptoms in acutely disturbed patients.

Izraēla - angļu - Ministry of Health

novartis israel ltd - octreotide - solution for injection / infusion - octreotide 0.1 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.

Izraēla - angļu - Ministry of Health

novartis israel ltd - octreotide - solution for injection / infusion - octreotide 0.05 mg/ml - octreotide - octreotide - prevention of complications following pancreatic surgery. symptomatic control and reduction of gh and igf-1plasma levels in patients with acromegaly who are inadequately controlled by surgery or radiotherapy. sandostatin treatment is also indicated for acromegalic patients unfit or unwilling to undergo surgery or in the interim period until radiotherapy becomes fully effective. relief of symptoms associated with functional gastroenteropancreatic endocrine tumours: - carcinoid tumours with features of the carcinoid syndrome - vipomas - glucagonomas - gastrinomas / zollinger-ellison syndrome usually in conjunction with proton pump inhibitors or h2- antagonist therapy - insulinomas for pre-operative control of hypoglycaemia and for maintenance therapy - grfomas. sandostatin is not an antitumour therapy and is not curative in these patients.emergency management of bleeding gastro-oesophageal varices secondary to cirrhosis in combination with specific therapy such as endoscopic sclerotherapy.